These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 20381786

  • 1. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K.
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [Abstract] [Full Text] [Related]

  • 2. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA, Shahien EA, Hussein AM.
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [Abstract] [Full Text] [Related]

  • 4. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W.
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
    Lupinacci AP, Calzada JI, Rafieetery M, Charles S, Netland PA.
    Adv Ther; 2009 Feb; 26(2):208-16. PubMed ID: 19234680
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [Abstract] [Full Text] [Related]

  • 7. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
    Fakhraie G, Katz LJ, Prasad A, Eslami Y, Sabour S, Zarei R, Moghimi S.
    J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A, Spratt A, Ogunbowale L, dell'Omo R, Kulkarni A, Bunce C, Franks WA.
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [Abstract] [Full Text] [Related]

  • 9. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J, Auriol S, Mahieu-Durringer L, Ancèle E, Pagot-Mathis V, Mathis A.
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Nov; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 11. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU.
    Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Aug; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 14. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.
    Ghosh S, Singh D, Ruddle JB, Shiu M, Coote MA, Crowston JG.
    Clin Exp Ophthalmol; 2010 May; 38(4):353-7. PubMed ID: 20665941
    [Abstract] [Full Text] [Related]

  • 15. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO, Albert MA, Mays A, Vail R.
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract] [Full Text] [Related]

  • 16. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
    Chen CH, Lai IC, Wu PC, Chen YJ, Chen YH, Lee JJ, Liu YC, Kuo HK.
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
    [Abstract] [Full Text] [Related]

  • 17. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
    Higashide T, Murotani E, Saito Y, Ohkubo S, Sugiyama K.
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499
    [Abstract] [Full Text] [Related]

  • 18. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S, Buchacra O, Milla E, Andreu D, Tellez J.
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [Abstract] [Full Text] [Related]

  • 19. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
    Sothornwit N.
    J Med Assoc Thai; 2008 May; 91 Suppl 1():S162-5. PubMed ID: 18672609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.